Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 02:15:12 UTC
Update Date2021-09-26 22:59:17 UTC
HMDB IDHMDB0248803
Secondary Accession NumbersNone
Metabolite Identification
Common NameAzilsartan medoxomil
Descriptionazilsartan medoxomil, also known as edarbi, belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. Based on a literature review a significant number of articles have been published on azilsartan medoxomil. This compound has been identified in human blood as reported by (PMID: 31557052 ). Azilsartan medoxomil is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Azilsartan medoxomil is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
Azilsartan medoxomiloChEBI
Azilsartanum medoxomilumChEBI
EdarbiChEBI
TAK 491MeSH
TAK-491MeSH
Chemical FormulaC30H24N4O8
Average Molecular Weight568.5336
Monoisotopic Molecular Weight568.159413764
IUPAC Name(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
Traditional Nameazilsartan medoxomil
CAS Registry NumberNot Available
SMILES
CCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O1
InChI Identifier
InChI=1S/C30H24N4O8/c1-3-38-28-31-23-10-6-9-22(27(35)39-16-24-17(2)40-30(37)41-24)25(23)34(28)15-18-11-13-19(14-12-18)20-7-4-5-8-21(20)26-32-29(36)42-33-26/h4-14H,3,15-16H2,1-2H3,(H,32,33,36)
InChI KeyQJFSABGVXDWMIW-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassBiphenyls and derivatives
Direct ParentBiphenyls and derivatives
Alternative Parents
Substituents
  • Biphenyl
  • Phenyl-1,2,4-oxadiazole
  • Benzimidazole
  • Alkyl aryl ether
  • Carbonic acid diester
  • N-substituted imidazole
  • 1,2,4-oxadiazole
  • Azole
  • Heteroaromatic compound
  • Imidazole
  • Vinylogous amide
  • Oxadiazole
  • Carboxylic acid ester
  • Oxacycle
  • Carboxylic acid derivative
  • Azacycle
  • Ether
  • Organoheterocyclic compound
  • Monocarboxylic acid or derivatives
  • Organic oxygen compound
  • Organic nitrogen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP4.94ALOGPS
logP6.03ChemAxon
logS-4.9ALOGPS
pKa (Strongest Acidic)9.21ChemAxon
pKa (Strongest Basic)1.75ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area139.57 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity149.52 m³·mol⁻¹ChemAxon
Polarizability57.73 ųChemAxon
Number of Rings6ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+223.80330932474
DeepCCS[M-H]-221.51130932474
DeepCCS[M-2H]-254.75130932474
DeepCCS[M+Na]+229.71630932474
AllCCS[M+H]+232.632859911
AllCCS[M+H-H2O]+231.032859911
AllCCS[M+NH4]+234.032859911
AllCCS[M+Na]+234.432859911
AllCCS[M-H]-213.732859911
AllCCS[M+Na-2H]-214.132859911
AllCCS[M+HCOO]-214.732859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
Azilsartan medoxomilCCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O15710.4Standard polar33892256
Azilsartan medoxomilCCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O14503.6Standard non polar33892256
Azilsartan medoxomilCCOC1=NC2=C(N1CC1=CC=C(C=C1)C1=CC=CC=C1C1=NOC(=O)N1)C(=CC=C2)C(=O)OCC1=C(C)OC(=O)O15005.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Azilsartan medoxomil,1TMS,isomer #1CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NOC(=O)N2[Si](C)(C)C)C=C14825.3Semi standard non polar33892256
Azilsartan medoxomil,1TMS,isomer #1CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NOC(=O)N2[Si](C)(C)C)C=C14646.6Standard non polar33892256
Azilsartan medoxomil,1TMS,isomer #1CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NOC(=O)N2[Si](C)(C)C)C=C16521.5Standard polar33892256
Azilsartan medoxomil,1TBDMS,isomer #1CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NOC(=O)N2[Si](C)(C)C(C)(C)C)C=C14979.5Semi standard non polar33892256
Azilsartan medoxomil,1TBDMS,isomer #1CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NOC(=O)N2[Si](C)(C)C(C)(C)C)C=C14786.7Standard non polar33892256
Azilsartan medoxomil,1TBDMS,isomer #1CCOC1=NC2=CC=CC(C(=O)OCC3=C(C)OC(=O)O3)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NOC(=O)N2[Si](C)(C)C(C)(C)C)C=C16421.8Standard polar33892256
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 10V, Positive-QTOFsplash10-0wmi-0200290000-dd7d3ecb1bbc0e0666162017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 20V, Positive-QTOFsplash10-03di-1901660000-a06fd917af594a222ba12017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 40V, Positive-QTOFsplash10-03xr-0519600000-ba42cf49a4852e899e172017-07-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 10V, Negative-QTOFsplash10-0829-1000890000-ba2719f1cbbe2ad452562017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 20V, Negative-QTOFsplash10-08fr-0200910000-3a396b812de267381c632017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 40V, Negative-QTOFsplash10-0006-3209300000-a3ca8c482db2df432f5e2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 10V, Positive-QTOFsplash10-014r-0000390000-0aaa59a3dbdc1bcbafe32021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 20V, Positive-QTOFsplash10-000i-0021960000-f2ab467be2700ff9e0862021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 40V, Positive-QTOFsplash10-0uxr-2494010000-474417c85a307440ab2f2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 10V, Negative-QTOFsplash10-02t9-2202790000-6fb88e3c2d7aa2532cdf2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 20V, Negative-QTOFsplash10-0odi-2001970000-cb35e28d6191185d1cbc2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Azilsartan medoxomil 40V, Negative-QTOFsplash10-0f6x-5022910000-fdb6bb186fe75548c2f92021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9413866
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkAzilsartan
METLIN IDNot Available
PubChem Compound11238823
PDB IDNot Available
ChEBI ID68845
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]